MAP1LC3A and Miyoshi myopathy: In contrast, SK1-I treatment induced a dose-dependent activation of autophagy in both MM cell types, as shown by the conversion, via lipidation, of microtubule-associated protein 1 light-chain 3 (LC3) from LC3-I (free form) to LC3-II (membrane-bound form) (Figure 7A both panels).